U-Chart Analysis:EIKEN CHEMICAL CO.,LTD.:4549

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index EIKEN CHEMICAL CO.,LTD. Go to web site 4549 Medicals 東証プライム March 1, 2000 1990.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

EIKEN CHEMICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

EIKEN CHEMICAL CO.,LTD. Balance Sheet 2025年3月期 EIKEN CHEMICAL CO.,LTD. Balance Sheet 2024年3月期 EIKEN CHEMICAL CO.,LTD. Balance Sheet 2023年3月期 EIKEN CHEMICAL CO.,LTD. Balance Sheet 2022年3月期 EIKEN CHEMICAL CO.,LTD. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 9,873 16,308 18,317 16,121 9,150
Other Current AssetsHelp 21,659 21,543 20,900 20,918 20,833
Tangible Fixed AssetsHelp 22,121 17,005 17,202 15,275 12,768
Intangible Fixed AssetHelp 670 792 1,054 1,350 1,450
Investments and OthersHelp 8,049 6,003 8,802 8,848 11,484
Total AssetsHelp 62,372 61,651 66,275 62,512 55,685
Total Current LiabilitiesHelp 14,737 11,729 12,821 12,911 13,231
Total Long-term LiabilitiesHelp 4,038 3,951 3,919 3,798 782
Shareholder's EquityHelp 43,597 45,971 49,535 45,803 41,672
Total LiabilitiesHelp 62,372 61,651 66,275 62,512 55,685

EIKEN CHEMICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

EIKEN CHEMICAL CO.,LTD. Profit and Loss Account 2025年3月期 EIKEN CHEMICAL CO.,LTD. Profit and Loss Account 2024年3月期 EIKEN CHEMICAL CO.,LTD. Profit and Loss Account 2023年3月期 EIKEN CHEMICAL CO.,LTD. Profit and Loss Account 2022年3月期 EIKEN CHEMICAL CO.,LTD. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 40,539 40,052 43,271 42,996 38,667
Total Sales 40,539 40,052 43,271 42,996 38,667
Cost of SalesHelp 24,027 23,328 22,765 22,431 20,137
Other Costs and RevenueHelp 14,284 14,090 14,770 14,346 13,485
Total CostsHelp 38,311 37,418 37,535 36,777 33,622
Net RevenueHelp 16,512 16,724 20,506 20,565 18,530
Earnings Before TaxHelp 2,991 3,503 7,592 8,482 6,870
Net IncomeHelp 2,228 2,634 5,736 6,219 5,045
Net Income 2,228 2,634 5,736 6,219 5,045

EIKEN CHEMICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

EIKEN CHEMICAL CO.,LTD. Cash Flow Statement 2025年3月期 EIKEN CHEMICAL CO.,LTD. Cash Flow Statement 2024年3月期 EIKEN CHEMICAL CO.,LTD. Cash Flow Statement 2023年3月期 EIKEN CHEMICAL CO.,LTD. Cash Flow Statement 2022年3月期 EIKEN CHEMICAL CO.,LTD. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 6,032 3,806 7,575 7,769 5,451
Investing Cash Flow(ICF)Help -4,499 -2,216 -316 -5,044 -2,193
Financing Cash FlowHelp -4,857 -6,694 -2,095 1,200 -1,275
Exchange Difference of Cash and Cash EquivalentsHelp -2 6 0 6 4
Net Increase and Decrease in Cash and Cash Equivalentsn -3,326 -5,098 5,164 3,931 1,987

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

EIKEN CHEMICAL CO.,LTD.

Company where related level is highHelp

KAINOS Laboratories,Inc.
SAWAI PHARMACEUTICAL CO.,LTD.
MEDICAL & BIOLOGICAL LABORATORIES CO.
SSP CO.,LTD.
WAKAMOTO PHARMACEUTICAL CO.,LTD.
SAWAI GROUP HOLDINGS Co., Ltd.
Veritas In Silico
Chiome Bioscience Inc.
ROHTO PHARMACEUTICAL CO.,LTD.
Noile-Immune Biotech Inc.